Foundation for Clinical and Applied Cancer Research
- Research works
- 115 ▲ 50% vs 2013–17
- Citations
- 957 8.3 per fractional work
- Top-10% rate
- 7.6% record average 16.5%
- Open access
- 76% world 28%
Not ranked overall: Foundation for Clinical and Applied Cancer Research is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
What does Foundation for Clinical and Applied Cancer Research specialise in?
Where its research is concentrated relative to its size: Medicine takes 3.5× the share of its output that it takes of world research.
- MedicineField · 26.8 works3.5×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.5×. Every wedge is a field page.
- Medicine 3.5×
- Biochemistry, Genetics and Molecular Biology 2.6×
- Economics, Econometrics and Finance 1.6×
- Dentistry 1.4×
- Immunology and Microbiology 1.1×
- Psychology 0.8×
- Health Professions 0.7×
- Neuroscience 0.3×
- Social Sciences 0.3×
- Pharmacology, Toxicology and Pharmaceutics 0.3×
- Engineering 0.1×
- Materials Science 0.1×
- Chemistry 0.1×
- Environmental Science 0.1×
- Mathematics 0.1×
- Business, Management and Accounting 0.1×
- Computer Science 0.0×
- Physics and Astronomy 0.0×
Which keywords describe research at Foundation for Clinical and Applied Cancer Research?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Targeted Therapy, Clinical Trials, Chemotherapy, Immunotherapy, Genomic Profiling, Treatment Guidelines, ALK Inhibitors and EGFR Mutations.
- Radiation Therapy
- Radiosurgery
- Positron Emission Tomography
- Mutational Signatures
- Judicialization
- Cytoreductive Surgery
- Cancer Genomics
- Tumor Microenvironment
- Tumor Staging
- Healthcare Access
- Adjuvant Therapy
- Small-Cell Lung Cancer
- Tumor Markers
- Metastasis
- Radiotherapy
- Quality of Life
- EGFR Mutations
- Treatment Guidelines
- Immunotherapy
- Clinical Trials
- Targeted Therapy
- Chemotherapy
- Genomic Profiling
- ALK Inhibitors
- Biomarkers
- Epidemiology
- Prognostic Factors
- Survival Analysis
- Genomic Profiles
- Clinical Practice Guidelines
- Genetic Mutations
- Lung Cancer
- Genomic Instability
- CT Screening
- Cost-effectiveness Analysis
- Health Utility Measures
- Medication
- Ovarian Cancer
- Molecular Characterization
- Cancer Risk
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Targeted Therapy7▲ 80×4 topics
- Clinical Trials7▲ 26×6 topics
- Chemotherapy6▲ 22×15 topics
- Immunotherapy6▲ 21×13 topics
- Genomic Profiling4▲ 101×2 topics
- Treatment Guidelines4▲ 44×2 topics
- ALK Inhibitors4▲ 150×1 topic
- EGFR Mutations4▲ 150×1 topic
- Biomarkers3▲ 12×8 topics
- Quality of Life3▲ 6.0×11 topics
- Epidemiology3▲ 1.98×25 topics
- Radiotherapy3▲ 19×6 topics
- Prognostic Factors3▲ 16×8 topics
- Metastasis2▲ 19×3 topics
- Survival Analysis2▲ 19×6 topics
- Tumor Markers2▲ 64×2 topics
- Genomic Profiles2▲ 115×1 topic
- Small-Cell Lung Cancer2▲ 115×1 topic
- Clinical Practice Guidelines2▲ 8.6×8 topics
- Adjuvant Therapy2▲ 30×2 topics
- Genetic Mutations2▲ 8.9×7 topics
- Healthcare Access1▲ 13×2 topics
- Lung Cancer1▲ 21×2 topics
- Tumor Staging1▲ 31×2 topics
- Genomic Instability1▲ 29×2 topics
- Tumor Microenvironment1▲ 7.4×6 topics
- CT Screening1▲ 45×1 topic
- Cancer Genomics1▲ 43×1 topic
- Cost-effectiveness Analysis1▲ 37×1 topic
- Cytoreductive Surgery1▲ 45×2 topics
- Health Utility Measures1▲ 37×1 topic
- Judicialization1▲ 109×1 topic
- Medication1▲ 109×1 topic
- Mutational Signatures1▲ 43×1 topic
- Ovarian Cancer1▲ 34×2 topics
- Positron Emission Tomography1▲ 45×1 topic
- Molecular Characterization1▲ 15×4 topics
- Radiosurgery1▲ 30×2 topics
- Cancer Risk1▲ 12×4 topics
- Radiation Therapy1▲ 20×4 topics
Which research topics does Foundation for Clinical and Applied Cancer Research publish most on?
By volume in 2022–2025: Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Public Health in Brazil and Cancer Genomics and Diagnostics.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 4 works
- 2 Lung Cancer Research Studies Oncology 2 works
- 3 Public Health in Brazil Sociology and Political Science 1 works
- 4 Cancer Genomics and Diagnostics Cancer Research 1 works
- 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 6 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
- 7 Brain Metastases and Treatment Pulmonary and Respiratory Medicine 1 works
- 8 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 9 BRCA gene mutations in cancer Genetics 1 works
- 10 Intraperitoneal and Appendiceal Malignancies Surgery 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Foundation for Clinical and Applied Cancer Research's research output changed?
Output in 2018–2022 was 50% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Bogotá
- Universidad Nacional de Colombia
- Pontificia Universidad Javeriana
- Universidad de Los Andes
- Universidad Distrital Francisco José de Caldas
- Universidad del Rosario
- Military University Nueva Granada
- Universidad Libre de Colombia
- Universidad Externado de Colombia
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.